Noom Med vs Ro 2026: Costs, Medications and Coaching Compared

Noom Med vs Ro vs Trimi: Side-by-Side Comparison

The following table compares all three providers across the dimensions that matter most to patients choosing a GLP-1 weight loss program. Pricing reflects publicly available rates as of early 2026 and may change.

Note: Noom Med's 12-month total includes medication only at the lower end ($149 x 12 = $1,788) and medication plus app at the upper end. Actual costs depend on dose, plan length, and promotional pricing. Ro does not sell compounded GLP-1; it bills its membership and brand-name medication separately, and the medication price depends on the prescribed product and dose. Ro membership figures are Ro's published rates checked October 6, 2026; see our Ro pricing guide for current medication charges. Trimi's flat $99/month is consistent regardless of dose.

Pricing Breakdown: The Real Cost of Each Provider

Understanding the true cost of GLP-1 therapy through each provider requires looking beyond the headline monthly price. Noom Med and Ro both split their pricing into separate charges: Noom Med's medication subscription and behavioral coaching app are separate products that may be billed independently, and Ro bills its membership separately from the medication. Trimi's monthly price includes the medication.

Noom Med Pricing

Noom Med charges approximately $149 to $209 per month for semaglutide, with pricing that can vary based on dose and promotional offers. The Noom behavioral coaching app, which is Noom's original product and the feature that differentiates Noom Med from other prescribers, is a separate subscription that costs approximately $32 to $70 per month depending on plan length. Patients who want the full Noom experience (medication plus app-based coaching) can expect to pay $181 to $279 per month combined. Over 12 months, that totals $2,172 to $3,348 or more.

This split pricing model creates a common point of confusion. Patients who sign up for Noom Med expecting the behavioral coaching to be included may discover it requires an additional subscription. Conversely, existing Noom app subscribers who add medication may not realize the medication cost is on top of their current app fee. Before enrolling, confirm exactly what is and is not included in the quoted price.

Ro Pricing

Ro's weight loss program (Ro Body) does not sell compounded GLP-1. It prescribes FDA-approved brand-name medications, such as Wegovy (semaglutide) and Zepbound (tirzepatide), and bills two separate charges: a Ro Body membership of $39 for the first month, then $149 per month on monthly billing or $74 to $99 per month equivalent on prepaid plans, plus the medication, which is priced by product and dose. Insurance does not cover the membership. For current membership and medication charges, see our Ro pricing guide. For a step-by-step walkthrough of Ro's program, eligibility, and medications, see how Ro works for weight loss.

Because Ro prices the medication by product and dose, the monthly total can rise as patients titrate up to maintenance doses, and introductory medication offers can end after the first months. Add the membership fee to the prescribed medication charge to see the full monthly cost before enrolling.

Trimi Pricing

Trimi charges $99 per month for semaglutide and $125 per month for tirzepatide. This pricing is flat and dose-independent, patients pay the same amount whether they are on a starting dose or a full maintenance dose. The monthly fee includes the medication, provider consultations, dosage adjustments, and shipping. There are no app fees or enrollment charges; pricing reflects the annual plan (a 12-month commitment) backed by a 6-month money-back promise.

The Coaching Debate: Is Noom's Behavioral Program Worth the Premium?

The fundamental differentiator between Noom Med and Ro is behavioral coaching. Noom built its reputation on a psychology-based weight loss app before expanding into prescription medication, and the company positions the combination of medication plus behavioral coaching as its competitive advantage. The question for patients is whether that coaching justifies paying $32 to $70 more per month than a medication-only provider.

The clinical argument for combining behavioral therapy with GLP-1 medication has legitimate support. Research demonstrates that behavioral interventions can enhance and sustain weight loss outcomes when paired with pharmacotherapy. Patients who develop better eating habits, exercise routines, and psychological coping strategies during medication use may be better positioned to maintain weight loss if they eventually discontinue the medication. Noom's app uses cognitive behavioral therapy principles, food logging, educational articles, and group coaching to address the behavioral side of weight management.

However, there are important counterpoints. First, Noom's coaching is primarily algorithm-driven and delivered through an app rather than through one-on-one sessions with a clinical psychologist or certified obesity specialist. The level of personalization and clinical depth is not comparable to formal behavioral therapy conducted by a specialist. Second, GLP-1 medications themselves fundamentally alter the behavioral equation by reducing appetite, decreasing food noise, and making it physiologically easier to eat less, which means the behavioral challenges that coaching addresses are already significantly mitigated by the medication. Third, many patients report declining engagement with the Noom app over time while continuing to pay the subscription fee.

For patients who are new to weight management and want structured guidance alongside their medication, Noom's coaching may provide value during the initial months of treatment. For patients who are self-motivated, already knowledgeable about nutrition, or primarily seeking affordable medication access, the coaching premium is difficult to justify, particularly when managing side effects and maintaining treatment are the primary clinical needs rather than behavioral restructuring.

Ro's Approach: Medication-Focused Telehealth

Ro (originally launched as Roman for men's health) has evolved into one of the largest direct-to-consumer telehealth platforms in the United States. Unlike Noom, which started as a behavioral weight loss app, Ro built its business around convenient, affordable access to prescription medications across multiple health categories. The weight loss program, Ro Body, is one vertical within a broader platform that also covers sexual health, dermatology, hair loss, and other conditions.

This medication-first philosophy shapes the Ro weight loss experience. Patients complete an online health assessment, consult with a licensed provider, and receive their GLP-1 medication shipped to their door. The process is efficient and streamlined. Ro does not bundle extensive behavioral coaching or require patients to engage with a separate app curriculum. The clinical focus is on medication management: proper dosing, titration schedules, side effect management, and ongoing provider oversight.

For patients who view GLP-1 therapy as a medical treatment rather than a lifestyle program, Ro's approach is straightforward and practical. You get the medication, clinical oversight, and the flexibility to manage your own diet and exercise without paying for coaching services you may not use. The trade-off is that patients who genuinely need structured behavioral support will not find it through Ro's weight loss program.

Ro's broader telehealth platform is a minor advantage for patients who consolidate multiple health needs through a single provider. If you already use Ro for other prescriptions or services, adding weight loss medication to your existing account is convenient. However, this consolidation benefit is marginal, most patients choose their GLP-1 provider based on medication cost and clinical quality rather than whether the platform also sells hair loss treatments.

Clinical Evidence: What the Research Shows

The clinical evidence supporting GLP-1 medications for weight loss is robust, and it comes from trials of the FDA-approved brand-name products, not compounded preparations. Understanding this evidence helps patients evaluate whether the supplementary services offered by different providers meaningfully change outcomes, or whether the medication itself drives the majority of results.

The critical insight from these trials is that GLP-1 medications produce substantial weight loss with standard lifestyle counseling, the type of basic clinical guidance that all three providers (Noom Med, Ro, and Trimi) include in their programs. While intensive behavioral therapy can provide incremental benefit, the magnitude of that additional benefit is modest compared to the medication effect. Patients should weigh whether a small incremental improvement in outcomes justifies paying hundreds or thousands of dollars more per year in coaching fees. For more on how these medications work and their side effect profiles, see our clinical guides on semaglutide and tirzepatide.

Noom Med: Strengths and Limitations

Noom Med Strengths

Noom Med Limitations

Ro: Strengths and Limitations

Ro Strengths

Ro Limitations

The Bottom Line: Which Provider Should You Choose?

The choice between Noom Med, Ro, and Trimi depends on what you prioritize in a GLP-1 weight loss program. All three are legitimate providers with licensed clinicians, genuine medication, and functional treatment programs. The differences are in pricing, supplementary services, and overall value proposition.

If you are currently on Noom Med or Ro and considering a switch, our step-by-step guides walk you through the process: how to cancel Noom Med and switch providers and how to cancel Ro and switch providers. Switching is straightforward and does not require restarting your medication from scratch, your new provider can continue your current dose and titration schedule without interruption.